Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
J Pain Symptom Manage. 2021 Aug;62(2):242-251. doi: 10.1016/j.jpainsymman.2020.12.018. Epub 2020 Dec 28.
Palliative radiation therapy (RT) is frequently used to ameliorate cancer-associated symptoms and improve quality of life.
To examine how palliative care (PC) as a specialty is integrated at the time of RT consultation for patients with advanced cancer.
We retrospectively reviewed 162 patients with metastatic cancer who received palliative RT at our institution (7/2017-2/2018). Fisher's exact test identified differences in incidence of receiving any specialty PC. Logistic regression analyses determined predictors of receiving PC.
Of the 74 patients (46%) who received any specialty PC, 24 (32%) initiated PC within four weeks of RT consultation. The most common reasons for specialty PC initiation were pain (64%) and goals of care/end-of-life care management (23%). Referrals to specialty PC were made by inpatient care teams (48.6%), medical oncologists (48.6%), radiation oncologists (1.4%), and self-referring patients (1.4%). Patients with pain at RT consultation had a higher incidence of receiving specialty PC (58.7% vs. 37.4%, P = 0.0097). There was a trend toward decreased PC among patients presenting with neurological symptoms (34.8% vs. 50%, P = 0.084). On multivariable analysis, receiving specialty PC significantly differed by race (non-white vs. white, odds ratio [OR] = 6.295 [95% CI 1.951-20.313], P = 0.002), cancer type (lung vs. other histology, OR = 0.174 [95% CI 0.071-0.426], P = 0.0006), and RT consultation setting (inpatient vs. outpatient, OR = 3.453 [95% CI 1.427-8.361], P = 0.006).
Fewer than half of patients receiving palliative RT utilized specialty PC. Initiatives are needed to increase PC, especially for patients with lung cancer and neurological symptoms, and to empower radiation oncologists to refer patients to specialty PC.
姑息性放疗(palliative radiation therapy,RT)常用于缓解癌症相关症状并提高生活质量。
探讨在晚期癌症患者接受 RT 咨询时,姑息治疗(palliative care,PC)作为一个专业领域是如何融入其中的。
我们回顾性分析了在我院接受姑息性 RT 的 162 例转移性癌症患者(2017 年 7 月至 2018 年 2 月)。采用 Fisher 确切检验比较接受任何专科 PC 治疗的患者比例差异。采用逻辑回归分析确定接受 PC 的预测因素。
在 74 例(46%)接受任何专科 PC 治疗的患者中,有 24 例(32%)在 RT 咨询后 4 周内开始接受 PC。开始专科 PC 的最常见原因是疼痛(64%)和治疗目标/临终关怀管理(23%)。专科 PC 的转诊来自住院治疗团队(48.6%)、肿瘤内科医生(48.6%)、放疗科医生(1.4%)和患者自行转诊(1.4%)。在 RT 咨询时出现疼痛的患者接受专科 PC 的比例更高(58.7% vs. 37.4%,P=0.0097)。有神经系统症状的患者接受 PC 的比例呈下降趋势(34.8% vs. 50%,P=0.084)。多变量分析显示,种族(非白人 vs. 白人,比值比[OR] = 6.295 [95%可信区间 1.951-20.313],P=0.002)、癌症类型(肺癌 vs. 其他组织学类型,OR = 0.174 [95%可信区间 0.071-0.426],P=0.0006)和 RT 咨询地点(住院 vs. 门诊,OR = 3.453 [95%可信区间 1.427-8.361],P=0.006)是接受专科 PC 的显著预测因素。
接受姑息性 RT 的患者中,不足一半的患者接受了专科 PC。需要采取措施增加 PC 的使用,特别是对肺癌和有神经系统症状的患者,并赋予放疗科医生转介患者接受专科 PC 的权力。